🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to investigate the effects of aP booster vaccination in chi...
Status
Completed
Location
University of Turku
Start Date
2018-04-18
Trial ID
NCT03697798
Treatments Being Tested
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
This study will look at your body's response to the new immunizations. We w...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2007-07-10
Trial ID
NCT00505063
This study assessed the immunogenicity and safety of two vaccination regime...
Status
Completed
Location
Multiple Locations
Start Date
2001-09
Trial ID
NCT00366366
Treatments Being Tested
The purpose of the study is to compare the immunogenicity and safety of a b...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-01
Trial ID
NCT01245049
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
The aim of this study is to assess antibody persistence in infants who rece...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-30
Trial ID
NCT01358825
Treatments Being Tested
Assess the safety and immunogenicity of a 3-dose schedule (at 2, 4, 6 month...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-11
Trial ID
NCT02173704
Treatments Being Tested